Neurotrophins Market Players:
- Genentech, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Regeneron Pharmaceuticals, Inc.
- Biogen Inc.
- Amgen Inc.
- Eli Lilly and Company
- Novartis International AG
- Pfizer Inc.
- Roche Holding AG
- Johnson & Johnson
- AbbVie Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of neurotrophins is evaluated at USD 8.28 billion.
The global neurotrophins market size was worth over USD 7.77 billion in 2025 and is poised to grow at a CAGR of around 7.3%, reaching USD 15.72 billion revenue by 2035.
Asia Pacific neurotrophins market is projected to secure the largest share of 40%, driven by expanding international research collaborations and the growing role of patient advocacy groups supporting patient-centric neurological care.
Key players in the market include Genentech, Inc., Regeneron Pharmaceuticals, Inc., Biogen Inc., Amgen Inc., Eli Lilly and Company, Novartis International AG.
